Participants lost weight steadily for 14 months before plateauing
Calculate your final concentration based on the total water volume added, not just the second addition
10 Majority of patients had CVD and were receiving SOC 6,7,a 97% were receiving glucose-lowering medications 6 Patient characteristics at baseline (N=9650) 6,7 Select history of CVD at baseline (N=9650) 6 Select history of medication use at baseline (N=9650) 6,10 a Standard care consisted of glucose-lowering and cardiovascular riskreducing therapies administered in accordance with local guidelines
Does not include sales charges and assumes reinvestment of dividends and capital gains
Afterward, 1 mL of the SC medium was inoculated with 1% of a fresh overnight culture of S
[1] [2] According to the FDA prescribing information for Zepbound, in clinical trials, nausea occurred in approximately 24-29% of patients taking Zepbound (compared to 9% on placebo), while vomiting affected roughly 6-12% of users (versus 2% on placebo)
